Comparison of local tumor control in patients with HCC treated with SBRT or TACE: a propensity score analysis
Abstract: Background
As stereotactic body radiation therapy (SBRT) has shown to be effective and safe in patients with hepatocellular carcinoma (HCC), the aim of our propensity score matched analysis was to evaluate the efficacy of SBRT in comparison to transarterial chemoembolization (TACE) in intermediate and advanced HCC.
Methods
Patients treated with TACE (n = 367) and patients allocated to SBRT (n = 35) were enrolled in this study. Propensity score matching was performed to adjust for differences in baseline and tumor characteristics of TACE and SBRT patients. Local tumor control (LC) 1 year after treatment, overall survival (OS) and 1-year mortality were assessed.
Results
Patients treated with SBRT have received more prior HCC treatments compared to TACE patients. The LC 1 year after treatment in the unmatched cohort was 74.4% for TACE patients compared to 84.8% in the SBRT group. Patients treated with TACE showed significantly improved OS (17.0 months vs. 9.0 months, p = 0.016). After propensity score matching, the LC in the TACE (n = 70) and SBRT (n = 35) group was comparable (82.9% vs. 84.8%, p = 0.805) and OS did not differ significantly in both groups.
Conclusions
SBRT after prior HCC therapy in selected patients shows comparable LC at 1 year, OS and 1-year mortality compared to patients treated with TACE
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Schlagwort
-
Hepatozelluläres Adenom
- Ereignis
-
Veröffentlichung
- (wo)
-
Freiburg
- (wer)
-
Universität
- (wann)
-
2018
- Urheber
- DOI
-
10.1186/s12885-018-4696-8
- URN
-
urn:nbn:de:bsz:25-freidok-165436
- Rechteinformation
-
Kein Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
Entstanden
- 2018
Ähnliche Objekte (12)
Comparison of local tumor control in patients with HCC treated with SBRT or TACE: a propensity score analysis
Induktionschemotherapie gefolgt von kombinierter Radiochemotherapie bei der kurativen Therapie des lokal fortgeschrittenen Karzinoms des zervikalen Ösophagus
HCC-Biomarker in der Diagnostik und Therapie des Hepatozellulären Karzinoms (HCC) in verschiedenen Phasen der Erkrankung
Patterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCC
Progression patterns and therapeutic sequencing following immune checkpoint inhibition for HCC : : an international observational study
Tumor burden with AFP improves survival prediction for TACE-treated patients with HCC: an international observational study
Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study
Stereotactic body radiotherapy of adrenal metastases - a dose‐finding study
Stereotactic or conformal radiotherapy for adrenal metastases: Patient characteristics and outcomes in a multicenter analysis
Klinisches Vorgehen bei Leberabszessen
Prediction of survival among patients receiving transarterial chemoembolization for hepatocellular carcinoma : : a response‐based approach
Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study
Comparison of local tumor control in patients with HCC treated with SBRT or TACE: a propensity score analysis
Induktionschemotherapie gefolgt von kombinierter Radiochemotherapie bei der kurativen Therapie des lokal fortgeschrittenen Karzinoms des zervikalen Ösophagus
HCC-Biomarker in der Diagnostik und Therapie des Hepatozellulären Karzinoms (HCC) in verschiedenen Phasen der Erkrankung
Patterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCC
Progression patterns and therapeutic sequencing following immune checkpoint inhibition for HCC : : an international observational study
Tumor burden with AFP improves survival prediction for TACE-treated patients with HCC: an international observational study
Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study
Stereotactic body radiotherapy of adrenal metastases - a dose‐finding study
Stereotactic or conformal radiotherapy for adrenal metastases: Patient characteristics and outcomes in a multicenter analysis
Klinisches Vorgehen bei Leberabszessen
Prediction of survival among patients receiving transarterial chemoembolization for hepatocellular carcinoma : : a response‐based approach
Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study
Comparison of local tumor control in patients with HCC treated with SBRT or TACE: a propensity score analysis
Induktionschemotherapie gefolgt von kombinierter Radiochemotherapie bei der kurativen Therapie des lokal fortgeschrittenen Karzinoms des zervikalen Ösophagus
HCC-Biomarker in der Diagnostik und Therapie des Hepatozellulären Karzinoms (HCC) in verschiedenen Phasen der Erkrankung
Patterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCC
Progression patterns and therapeutic sequencing following immune checkpoint inhibition for HCC : : an international observational study
Tumor burden with AFP improves survival prediction for TACE-treated patients with HCC: an international observational study
Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study
Stereotactic body radiotherapy of adrenal metastases - a dose‐finding study
Stereotactic or conformal radiotherapy for adrenal metastases: Patient characteristics and outcomes in a multicenter analysis
Klinisches Vorgehen bei Leberabszessen
Prediction of survival among patients receiving transarterial chemoembolization for hepatocellular carcinoma : : a response‐based approach